Tobacco Control 2000;9(Suppl I):i42–i45
Implementing tobacco tracking codes in anindividual practice association or a network modelhealth maintenance organisation
Make up of PHS smoking cessation task force
Oregon is an individual practice association
model health maintenance organisation with
capitated model and more than 360 000 mem-
bers in our preferred provider model, which is
a discounted fee for service structure. PHS has
12 000 employees, over 1400 acute and longterm beds, and a demonstrated commitment to
programs are one of the top priorities for
reducing overall cardiac morbidity and mortal-
developed a multifaceted approach to tobacco
ity. A regional health system task force for
cessation (fig 1). The overall program starts
tobacco cessation comprised of key personnel
with a variety of cessation services oVered to
and stakeholders was formed in 1994 (table 1).
our patients. The group support program is a
The physician leader’s role was to educate
10 session behaviour modification class. The
medical care providers on smoking cessation,
telephone support program (“Free & Clear”,
while the program development administrator
Group Health Cooperative, Puget Sound) is
helped coordinate activities and was instru-
provided to members. The individual support
mental in securing funds for all initiatives.
intervention (one on one), for highly comorbid
Smoking Cessation
Health education played a critical role in
and Prevention, Providence Health
administration of the intensive cessation inter-
consists of individual counselling with a highly
System, Oregon, 9205
ventions and other member focused interven-
trained smoking cessation counsellor for 12
SW Barnes Road, Suite #25, Portland,
tions. Health plan involvement was important
months. The task force developed self help
OR 97225, USA;
in changing the benefit structure of the health
materials in Spanish and Russian. We have a
cbentzmd
plan to broaden coverage for smoking cessation
@providence.org C J Bentz
counter nicotine patch and bupropion (Zyban;GlaxoWellcome), which is linked to participa-tion in a structured behavioural modification
program. To any interested clinic, we oVer, at
no cost, a tailored training program based on
the 4A’s developed by the National Cancer
which draws from the “stages of change”theory3 and “self determination” theory.4
Assurance, and the eVorts in tobacco cessation
played an important role in that accreditation.
Specific groups are targeted for smoking cessa-
tion, including patients with coronary artery
disease, diabetes, and asthma. Members of the
PHS task force have been involved in commu-nity activities, such as the Tobacco Free Coali-
tion of Oregon, and have helped shape the state
of Oregon’s preventive strategy for the Oregon
We have also implemented a hospital based
smoking cessation intervention based on work
by Stevens et al.5 In this program, every patient
Providence Health System (PHS) smoking cessation and prevention program
admitted to a PHS hospital is asked about cur-
1999. TOFCO,Tobacco Free Coalition of Oregon; OMAP, Oregon Medicaid AssistanceProgram; PHP, Providence Health Plan; OHP, Oregon Health Plan; NCQA, NationalCommittee for Quality Assurance; HEDIS, Healthcare Employer Data Information Set;
department, and the smoking status of every
C.O.R.E. Centre for Outcomes Research and Education; EMR, electronic medical record;
patient is recorded in the hospital demographic
CAD, coronary artery disease; DM, diabetes mellitus; Prov-RN, a telephone point of servicepatient advice line; PCP, primary care physicians.
database. Lists of inpatient smokers are printed
Implementing tobacco tracking codesBuilding measurement into clinical practice7
+ Seek usefulness, not perfection, in the measurement
+ Use a balanced set of process, outcome, and cost measures
+ Keep the measurement simple (think big, but start small)
+ Write down operational definitions of the measures
0’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 2000
Smoking rates in PHS versus state of Oregon.
a novel method of tracking and providing feed-
each day in the respiratory care departments,
back to providers on the delivery of preventive
and dedicated respiratory therapists systemati-
cally provide a smoking cessation interventionto interested patients as a routine part of inpa-
Primary care quality bonus
tient care at no additional cost to patients.
We have developed a successful “primary care
quality bonus”, which pays primary care physi-
smoking cessation within the health system.
cians to deliver preventive health care. A small
His eVorts led to PHS being the first health
amount of the capitated payment is withheld
from the primary care providers ($2 per mem-
provide a financial incentive for primary care
ber per month). This withhold/bonus is paid to
physicians to address tobacco cessation in rou-
physicians according to their performance on
various measures. Physicians accrue points in
this bonus by achieving certain goals in access
smoking rates among Providence Health Plan
to care, patient satisfaction, and selected clini-
members. Smoking rates, as measured by the
cal quality measures issues. The quality bonus
program has resulted in improvement in meas-
ures of preventive health care delivery (fig 3).
were compared with a PHS survey using the
In order to build provider acceptance for the
same methodology. Over the last four years, we
have seen a significant decrease in self reported
bonus, we have adopted a “stepped approach”.
smoking rates, down to 17% in 1998 (fig 2).
This is a process by which the quality bonus
measure for smoking cessation changes over a
encountered in implementing tobacco cessa-
period of several years. Initially the goal of the
tion in all types of managed care settings.6 We
incentive is to build preventive care infrastruc-
confirmed that many of these barriers aVect
ture, then after we have at least 75% of our
our clinics. In an evaluation of smoking cessa-
clinics reporting that the infrastructure to
tion in one of our primary care oYces we found
deliver the preventive care is in place, achieving
that physicians faced time pressures, patient
the quality bonus will require attaining defined
issues, paperwork, and lack of incentive. We
performance targets. In 1999, to meet criteria
also found that medical assistants were too
for the quality bonus smoking cessation meas-
ure, providers need only show that they have a
frustrated by lack of provider interest. A
systematic approach to smoking cessation in
project of continuous quality improvement in
their oYce. This approach must be based on
one clinic simplified the medical assistant’s
the 4A’s: asking all patients about smoking sta-
role, gave them feedback on performance, and
tus, and for paediatric patients, asking about
provided several training sessions, resulting in
exposure to second hand smoke; advising all
dramatic improvement increases in tobacco
smokers to quit; assisting interested smokers in
developing a quit plan; arranging for follow up.
into routine primary care is needed if we
expect to have improvement in the delivery of
demonstrating, in a sample of medical records,
preventive health care in routine oYce settings.
that the 4A’s are taking place. Initially, the
A review by Nelson et al7 clearly laid out prin-
quality bonus will not measure the physicians’
ciples that were followed as we have developed
rates of performance of the 4A’s. This steppedapproach allows us to give an incentive for
building oYce infrastructure before giving anincentive for specific performance targets. As
we perfect our method of measurement we will
gradually incorporate performance targets into
Tracking codes for prevention Measurements of health care performance
require chart review, which is costly and time
consuming for both physicians and managed
sustainable in the long run. Since most private
practice physician oYces lack the infrastruc-
Quality bonus performance in PHS 1996-98.
ture to address tobacco use or other preventive
Tracking codes dictionary, based on HEDIS 3.0 quality measures and 1999 PHP quality bonus programInfluenza Dilated retinal exam
> 8 < 9.0 Negative both micro & macroalbuminuria
> 7 < 8.0 Positive either micro & macroalbuminuria Smoking cessation Non-smoker/remote quitter (> 6 months) Recent quitter (< 6 months) >130 < 160
> 100 < 130 ACE inhibitor use Prior total hysterectomy Bilateral mastectomy
Measures in bold are part of the PHS system 1999 tracking codes pilot initiative.
health care systematically, a new approach is
advise, assist, arrange), then it is necessary to
needed. We have developed a set of tracking
enable providers of health care to carry this
codes, similar to the current procedural termi-
+ If providers are expected to ask every patient
(MCOs) to measure and reimburse for delivery
this possible by having a clear policy in place
of these services.8 These prevention codes are
documented at the point of medical care by the
infrastructure to carry this out and achieve
physician, captured on fee slips, and submitted
to the MCO’s claims system. It is equally
+ If providers are expected to give cessation
important to track the exceptions to preventive
advice to all smokers, then the MCO needs
health care. For example, diabetics who are on
to create an incentive that encourages cessa-
angiotensin converting enzyme (ACE) inhibi-
screening for diabetic proteinuria. A prelimi-
+ If physicians are expected to assist interested
nary “dictionary” of prevention tracking codes
smokers in quitting, then the MCO needs to
has been developed (table 3), which includes a
provide training in smoking cessation and
set of codes to track tobacco use and provider
also provide the resources needed to help
+ If medical care providers are expected to
funded by a planning grant from the Robert
arrange for follow up visits for smoking ces-
results of this project, being piloted in oYces
using both paper based and electronic medical
aspect of cessation and allow appropriate
records, will be available at the RWJF’s
Conclusion
work of the PHS task force on smoking cessa-
eVorts to address tobacco use in our loosely
tion. Teamwork has contributed to the success
aYliated health care system. Everyone benefits
of this task force, which has received two
from improvement in the delivery of preventive
health care. To make progress in this area, and
again in 1999). No other group in our health
smoking cessation in particular, we need to be
system has won this award twice. Defining the
clear about who the real customer is. While the
roles of doctors and administrators has been
patient is the ultimate customer, the immediate
crucial to our success. If physicians are
customers are physicians and the physicians’
expected to deliver the 4A’s of smoking (ask,
Implementing tobacco tracking codes
7 Nelson EC, Splaine ME, Batalden PB, et al. Building meas-
infrastructure. We have demonstrated that our
urement and data collection into medical practice. Ann Intern Med 1998;128:460–6.
8 Powers M. “Tracking codes” may increase compliance with
delivery of preventive health care service, and
HEDIS. Capitation Management Report 1999;6:17–20.
we hope it will eventually improve the health ofour patients. Doctors are benefiting from
Questions and answers
enhanced revenue collections in the form of
quality bonus incentives. Our health systemwill save expenditures by avoiding chart review,
will benefit from improved public image, and
A: It is a team eVort to provide preventive
will continue to garner praise from external
programs. Thus, you really need to have team
reviewing organisations, such as the National
Q: Most of the large health organisations are
losing substantial amounts of money, thus
physicians does not automatically improve
incentives may be one of the first things to
quality of care. It takes teamwork. But if there
eliminate. Do you think that is the case?
is one thing that managed care can do, and has
A: In our MCO, there are several funds.
the promise to do, it is to improve delivery of
There is the institutional fund, which pays the
hospital, the referral fund which pays theproviders, and the PCP fund which goes to pay
1 US Department of Health and Human Services. How to help
primary care. Every single major fund is in a
your patients stop smoking. A National Cancer Institute
deficit right now. So, there is a huge outcry and
manual for physicians. Bethesda, Maryland: National Can-cer Institute, Smoking and Tobacco Control Program,
it is a time of turmoil. If there are funding cri-
1991 (NIH Publication No 92–3064).
ses, what better time and way to figure out
2 Lichtenstein E, Hollis JF, Severson HH, et al. Tobacco ces-
sation interventions in health care settings: rationale,
model, outcomes. Addictive Behav 1996;21:709–20.
advocate and go to the chief executive oYcer
3 Prochaska JO, DiClemente CC, Norcross JC. In search of
how people change: applications to addictive behaviors.
and say, “This is a great opportunity for us to
American Psychologist 1992;47:1102–14.
show what is most important about managed
4 Williams GC, Quill TE, Deci E, et al. The facts concerning
the recent carnival of smoking in Connecticut and
care—which is prevention, all types of preven-
elsewhere. Ann Intern Med 1991;115:59–63.
tion. These bonuses are important because it is
5 Stevens VJ, Flasgow RE, Hollis JF, et al. A smoking cessation
intervention for hospital patients. Med Care 1993;31:65–
how we are being measured; they demonstrate
the quality of our organization”. These are very
6 Davis RM. An overview of tobacco measures. Tobacco Con-trol 1998;7(suppl):S36–40, S47–9. Implementing tobacco tracking codes in an individual practice association or a network model health maintenance organisation Tob Controldoi: 10.1136/tc.9.suppl_1.i42
Updated information and services can be found at:
References
This article cites 6 articles, 1 of which can be accessed free at:
Email alerting
Receive free email alerts when new articles cite this article. Sign up in the
box at the top right corner of the online article.
Pioglitazone and Insulin: Effects on Tight Glycaemic Control Assessed by the Continuous Glucose Monitoring System (CGMS) A Monocentric, Parallel-Cohort Study Hunsrück Diabetic Centre, Simmern, GermanyDiabetes mellitus is accompanied by long-term microvascular, neurological, and macrovascular complications. These complications, including retinopathy, nephropathy, neuropathy, and cardiovasc